Faron Pharmaceuticals Oy
FPHAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $282 | $235 | $206 | $216 |
| - Cash | $10 | $7 | $7 | $7 |
| + Debt | $12 | $13 | $13 | $4 |
| Enterprise Value | $285 | $241 | $212 | $212 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$28 | -$27 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$31 | -$30 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.341 | -0.381 | -0.291 |
| % Growth | 99.9% | 10.4% | -31% | – |
| Operating Cash Flow | -$23 | -$24 | -$23 | -$22 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$23 | -$24 | -$23 | -$23 |